Drawing for PHARM-O-KIN

USPTO serial 76245372

PHARM-O-KIN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DALIER, JOHN DAVID
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHARM-O-KIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GARY BAKER

GARY BAKER RATNER & PRESTIA1563 BOXWOOD AVESAN LEANDRO, CA 94579UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical diagnostic reagents, namely, nucleotide and peptide arrays and sensitive biochemical coating sensors for scientific, industrial, photographic, forestry, agricultural, geodesic or research use; analytic and diagnostic preparations, namely micro arrays, for analysis of genetically modified or pathogenic organisms in foodstuffs and foodstuff components, all for scientific, industrial, agricultural or research use; analytical and diagnostic test kits consisting primarily of reagents and processing chemicals, but also containing patches, slides and solid, semi-solid, gel-like or fluid matrix materials, the kits being for scientific, industrial, agricultural or research useACTIVE—
005Sensitive coating diagnostic reagents for clinical, veterinary or medical use, namely nucleotide and peptide arrays and biochemical sensors; analytical and diagnostic test kits consisting primarily of medical diagnostic reagents, processing chemicals, but also containing patches, slides and solid, semi-sold, gel-like or fluid matrix materials, and kits being for clinical and medical use; nucleotide and peptide for arrays use in the fields of pharmacogenetics, genomics, scientific and research diagnostics, medicine, and biotechnologyACTIVE—
009Nucleotide and peptide arrays for DNA sequencing, receptor-ligand interaction, protein analysis, nucleic and hybridization and detection for use in scientific research and analytical as well as diagnostic purposes, computer software for use in performing, systemizing, analysis, evaluation and collection of analytical and diagnostic data in the field of genetic sequencing, hybridization analysis, SNP detection, nucleic acid detection and receptor-ligand interactionACTIVE—
016Printed matter, namely, books, brochures, folders, informational flyers, in the field of medicine, molecular biology research, agriculture and biotechnology, placards, mounted photographs, unmounted photographs, pictures, X-ray photographs and electronic images, posters and stickers, stationary writing paper and envelopes, printed instructional, educational, and teaching materials in medical and molecular biology science, plastic bags and sacks for merchandise packaging, namely, envelopes and pouches, plastic bubble packs for wrapping or packagingACTIVE—
042Scientific and industrial research for others namely, research and development services in the field of diagnostic chemicals, compounds and apparatus, biochemical sensors, measuring apparatus for research and development of products, separation and purification processes, processes for investigating foodstuffs and the environment; laboratory services provided by scientists, namely, testing, analysis and evaluation of goods and services of others for the purpose of certification; chemical analysis, diagnostic genetic testing and medical testing of animal, plant and human pathology and physiology; scientific research and development for new products and technologies for others; pharmaceutical consultation services; services in completion of licensing applications, namely, medical product licensing and food product registration with government agenciesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 16, 2004ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 1, 2004CFITCASE FILE IN TICRS—
Nov 11, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 19, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 30, 2003NPUBNOTICE OF PUBLICATION—
Jun 10, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 30, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 30, 2003MAILPAPER RECEIVED—
Oct 29, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 10, 2002REINREINSTATED—
Sep 5, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 26, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 26, 2002MAILPAPER RECEIVED—
Aug 22, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2002PETRPETITION TO REVIVE-RECEIVED—
Aug 22, 2002MAILPAPER RECEIVED—
Aug 5, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 5, 2002MAILPAPER RECEIVED—
Aug 3, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 26, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance